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Background: Joint Hypermobility Syndrome (JHS) is a heritable disorder associated 
with laxity and pain in multiple joints. Physiotherapy is the mainstay of treatment but 
there is little research investigating its effectiveness. The aim of this study was 
therefore to conduct a pilot randomised controlled trial (RCT) to determine the 
feasibility of conducting a future definitive RCT.  
 
Methods: A comprehensive physiotherapy intervention was developed in 
conjunction with patients and healthcare professionals. It was then piloted and 
refined on the basis of patient and physiotherapist feedback. A parallel two-arm pilot 
RCT in two UK secondary care NHS Trusts compared 'Advice' against 'Advice & 
Physiotherapy'. Inclusion criteria were: >16 years, a diagnosis of JHS, and no other 
musculoskeletal conditions causing pain. The Advice intervention was a one-off 
session, supplemented by advice booklets from the Hypermobility Syndromes 
Association and Arthritis Research UK. All patients could ask questions specific to 
their circumstances and received tailored advice. Participants were then randomly 
allocated to 'Advice' (no further advice or physiotherapy) or 'Advice & Physiotherapy' 
(an additional six 30 minute sessions over 4 months). The Physiotherapy 
intervention was supported by a patient handbook and delivered on a one-to-one 
patient-therapist basis. It aimed to increase patients’ physical activity through 
developing knowledge, understanding and skills to better manage their condition. 
The primary outcome related to the feasibility of conducting a future definitive RCT. 
Qualitative interviews with patients and physiotherapists therefore formed a major 
component of data collection. Secondary outcomes included clinical measures 
(physical function, pain, global status, self-reported joint count, quality of life, 
exercise self-efficacy and adverse events); resource use (to estimate cost-
effectiveness); and an estimate of the value of information from a future RCT. 
Outcomes were recorded at baseline, 4 months (at the end of physiotherapy) and 7 
months (3 months following physiotherapy).  
 
Results: A total of n=29 participants were recruited to the pilot RCT. Recruitment 
was challenging, primarily due to a perceived lack of equipoise between Advice and 
Physiotherapy. The qualitative evaluation provided very clear guidance to inform a 
future RCT, including enhancement of the Advice intervention. Some patients 
reported that the Advice intervention was useful and the Physiotherapy intervention 
was evaluated very positively. The rate of return of questionnaires was low within the 
Advice group but reasonable in the Physiotherapy group. The Physiotherapy 
intervention showed evidence of promise in terms of primary and secondary clinical 
outcomes. The Advice arm experienced more adverse events. The value of 
information estimate indicated the potential for high value from a future RCT.  
 
Conclusion: A future definitive RCT of physiotherapy for JHS seems feasible, 
although the Advice intervention should be made more robust to address perceived 
equipoise and subsequent attrition. 
